Related Experiment Video
Updated: Aug 11, 2026

Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues
Nathan K LeBrasseur1, Meghan Kelly, Tsu-Shuen Tsao
1Diabetes and Metabolism Research Unit, Boston University School of Medicine, 650 Albany St., X-820, Boston, MA 02118, USA.
Abstract:
Thiazolidinediones (TZDs) are insulin-sensitizing agents used in the treatment of type 2 diabetes. A widely held view is that their action is secondary to transcriptional events that occur when TZDs bind to the nuclear receptor PPARgamma in the adipocyte and stimulate adipogenesis. It has been proposed that this increases insulin sensitivity, at least in part, by increasing the expression and release of adiponectin, an adipokine that activates the fuel-sensing enzyme AMP-activated protein kinase (AMPK). In this study, we report that TZDs also acutely activate AMPK in skeletal muscle and other tissues by a mechanism that is likely independent of PPARgamma-regulated gene transcription. Thus incubation of isolated rat EDL muscles in medium containing 5 microM troglitazone for 15 min (too brief to be attributable to transcription) significantly increased pAMPK and pACC. At a concentration of 100 microM, troglitazone maximally increased these parameters and caused twofold increases in 2-deoxy-d-glucose uptake and the oxidation of exogenous [(14)C]palmitate. Time course studies revealed that troglitazone-induced increases in pAMPK and pACC abundance at 15 min were paralleled by an increase in the AMP-to-ATP ratio and that by 60 min all of these parameters had returned to baseline values. Increases in pAMPK and pACC were also observed in skeletal muscle, liver, and adipose tissue in intact rats 15 min after the administration of a single dose of troglitazone (10 mg/kg, ip). Likewise, troglitazone and another TZD, pioglitazone, caused rapid increases in pAMPK and pACC of equal magnitude in Swiss 3T3 fibroblasts with and without sufficient PPARgamma to mediate the expression of target genes. The results indicate that TZDs can act within minutes to activate AMPK in mammalian tissues. They suggest that this effect is associated with a change in cellular energy state and that it is not dependent on PPARgamma-mediated gene transcription.
Insights
Thiazolidinediones (TZDs) rapidly activate AMP-activated protein kinase (AMPK) in tissues, independent of gene transcription. This acute effect on AMPK is linked to cellular energy changes and improves glucose uptake and fatty acid oxidation.
Area of Science:
- Molecular Endocrinology
- Metabolic Regulation
- Pharmacology
Background:
- Thiazolidinediones (TZDs) are established insulin-sensitizing agents for type 2 diabetes.
- Current understanding links TZD efficacy to PPARgamma-mediated adipogenesis and adiponectin release.
- Adiponectin is known to activate AMP-activated protein kinase (AMPK), a key metabolic regulator.
Purpose of the Study:
- To investigate the acute effects of TZDs on AMPK activation.
- To determine if TZD-induced AMPK activation is dependent on PPARgamma-mediated gene transcription.
Main Methods:
- Incubation of isolated rat EDL muscles with troglitazone.
- Measurement of phosphorylated AMPK (pAMPK) and phosphorylated ACC (pACC) levels.
- Assessment of glucose uptake and fatty acid oxidation rates.
- In vivo studies in rats and experiments with Swiss 3T3 fibroblasts.
Main Results:
- Short-term troglitazone treatment rapidly increased pAMPK and pACC in isolated muscles.
- This acute activation correlated with increased glucose uptake and fatty acid oxidation.
- TZDs also acutely activated AMPK in various tissues in vivo and in cell lines, irrespective of PPARgamma status.
Conclusions:
- TZDs can acutely activate AMPK within minutes in mammalian tissues.
- This rapid AMPK activation is associated with altered cellular energy status (AMP:ATP ratio).
- The mechanism of acute TZD action on AMPK appears independent of PPARgamma-mediated gene transcription.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
Oral Hypoglycemic Agents: Biguanides and Glitazones
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways
Dipeptidyl Peptidase 4 Inhibitors